The Biden administration further restricted US companies from selling 5 G-related items to China’s Huawei Technologies Co by amending their licenses.
The amendment would make the licenses more consistent with the tougher policies implemented by the Trump administration.
The new conditions could disrupt existing contracts with Huawei previously agreed upon under previous licenses.
The Commerce Department granted the initial export licenses after placing Huawei on its trade blacklist in 2019 over US national security concerns..
A revised license that took effect March 9th prohibited items that usable with or in any 5G devices. Another amended license that took effect on March 8 had a prohibition for using in the military, 5G, critical infrastructure, enterprise data centers, cloud, or space applications.
The notice also required certain items must have a density of not more than 6 gigabytes and other technical specifications.
Both revised licenses also mandated Huawei or customers to implement a parts control plan and make inventory records available to the US government upon request before export.
Some 300 applications with a valued $296 billion were pending as of January.


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Anta Sports Expands Global Footprint With Strategic Puma Stake
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



